| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 52.5% | 25.89% | -8.8% | 72/140 | 52.37% | 健帆生物 | 78.46% | 行业排名> |
| 2025-12-31 | 57.57% | 3.72% | 4.63% | 62/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 55.03% | 4.94% | -2.05% | 65/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 56.18% | 12.41% | 34.7% | 67/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 41.71% | -29.35% | -24.86% | 87/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 55.51% | -2.84% | 5.85% | 67/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 52.44% | -18.19% | 4.92% | 71/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 49.98% | -24.43% | -15.35% | 77/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 59.04% | -15.5% | 3.34% | 57/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 57.13% | 6.36% | -10.88% | 63/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 64.1% | 14.71% | -3.07% | 46/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 66.13% | 16.19% | -5.35% | 40/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 69.87% | 11.32% | 30.08% | 27/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 53.71% | -9.79% | -3.88% | 70/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 55.88% | -9.05% | -1.82% | 64/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 56.92% | -10.11% | -9.31% | 67/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 62.76% | -5.11% | 5.42% | 52/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 59.54% | -5.51% | -3.09% | 67/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 61.44% | -10.28% | -2.97% | 56/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 63.32% | -10.39% | -4.27% | 56/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 66.14% | -12.54% | 4.97% | 43/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 63.01% | -13.83% | -7.98% | 64/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 68.47% | -5.6% | -3.1% | 34/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 70.67% | -1.77% | -6.56% | 34/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 75.63% | 2% | 3.43% | 18/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 73.12% | -0.84% | 0.81% | 28/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 72.54% | 2% | 0.84% | 16/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 71.94% | 2% | -2.45% | 22/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2018-12-31 | 73.74% | -0.45% | -0.45% | 29/140 | 56.22% | 正海生物 | 93.09% | 行业排名> |
| 2017-12-31 | 74.08% | -2.58% | -2.58% | 23/140 | 56.1% | 正海生物 | 93.85% | 行业排名> |
| 2016-12-31 | 76.04% | 2% | 2% | 16/140 | 57.35% | 正海生物 | 93.08% | 行业排名> |

微信公众号
证券之星APP


